Palumbo Wealth Management’s Elevation Oncology ELEV Stock Holding History

Palumbo Wealth Management’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-295,328	Closed	-$108K	–	193
2025 Q2	$108K	Buy	295,328 +17,326	+6%	+$5.78K	0.03%	195
2025 Q1	$72K	Buy	278,002 +208,897	+302%	+$119K	0.02%	183
2024 Q4	$38.9K	Buy	69,105 +51,590	+295%	+$30.5K	0.01%	175
2024 Q3	$10.5K	Buy	17,515 +6,249	+55%	+$9.27K	﹤0.01%	160
2024 Q2	$30.4K	Sell	11,266 -6,477	-37%	-$24.4K	0.01%	150
2024 Q1	$91K	Buy	+17,743	New	+$57.5K	0.04%	130

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Palumbo Wealth Management's ELEV Position: Q3 2025 in Review

Palumbo Wealth Management sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 295,328 shares — an estimated $108K sold.

Palumbo Wealth Management first reported a position in ELEV in Q1 2024 and held it in 6 quarters. The position peaked at $108K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Palumbo Wealth Management reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Palumbo Wealth Management sold 295,328 Elevation Oncology shares in Q3 2025, an estimated $108K.
Palumbo Wealth Management first reported a position in Elevation Oncology in Q1 2024 and held it in 6 quarters.
Palumbo Wealth Management's Elevation Oncology position peaked at $108K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Palumbo Wealth Management's 13F filing for Q3 2025, filed 10 Nov 2025.